RKDA   $1.3  -5.80% Market Closed

Arcadia Biosciences, Inc.
Total Cash 8.11M
totalCashPerShare 5.949
EBITDA -13.25M
Total Debt 574.00K
quickRatio 3.317
currentRatio 4.609
Total Revenue 5.24M
debtToEquity 4.963
Revenue/Share 3.85
ROA -0.38159
ROE -0.54792
grossProfits
freeCashflow -7.43M
operatingCashflow -12.70M
earningsGrowth 0.28
revenueGrowth 0.007
grossMargins 0.20957
ebitdaMargins -2.52651
operatingMargins -1.54671
profitMargins -1.2932899
enterpriseValue -2.55M
forwardPE -3.1132812
floatShares 1.35M
sharesOutstanding 1.36M
sharesShort 17.40K
sharesShortPriorMonth 26.05K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.03%
Short Ratio help_outline 3.10%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 8.588
Price To Book help_outline 0.46
earningsQuarterlyGrowth 0.29
netIncomeToCommon -8.03M
trailingEps -6.17%
forwardEps -1.28%
enterpriseToEbitda 0.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.81 3Q 2024
institutionsCount 14
lastUpdated Nov. 6, 2024, 6:30 p.m.